BLUTTESTVORRICHTUNG

European patent · EP4261539 · In force

Register entry

Publication number
EP4261539
Application number
EP22813388
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 24, 2022
Published
Oct 18, 2023
Granted
Sep 11, 2024
Protection ends at the latest
Feb 23, 2042
Next annual fee due
Feb 28, 2027
IPC classes
G01N 33/52 (2006.01)
PCT application
PCT/JP2022/007627 24.02.2022
PCT publication
WO2023/162095 31.08.2023
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Jul 23, 2025

    Change

    Published in Swissreg on 23.07.2025

  3. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  4. Sep 17, 2024

    Agent entered

    Representative
    Dennemeyer AG, Bahnhofstrasse 23, 6300 Zug

    Published in Swissreg on 17.09.2024

  5. Sep 11, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.09.2024

Parties

Holder

Cellspect Co., Ltd.

2-4-23, Kitaiioka, Morioka-shi, Iwate 020-0857, JP

Agent

Dennemeyer AG

Bahnhofstrasse 23, 6300 Zug

Inventor

KIM, Seung Kyum

Morioka City, Iwate 0200857, JP

EDURA, Tomohiko

Morioka City, Iwate 0200857, JP

ITO, Takashi

Morioka City, Iwate 0200857, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.